Latest Plateletpheresis Stories
For the first time, researchers have successfully injected cultured red blood cells (cRBCs) created from human hematopoietic stem cells (HSCs) into a human donor.
Two New Web Sites, New Points Policy Offer Greater Rewards NEW YORK, April 7, 2011 /PRNewswire-USNewswire/ -- New York Blood Center (NYBC), serving more than 20 million people in New York City, Long Island, the Hudson Valley, New Jersey, and parts of Connecticut and Pennsylvania, has re-launched two of its web sites newly designed to be more user friendly, and announced an enhancement to its Donor Advantage Program to recognize and reward frequent blood donors. New York Blood Center's primary...
LAKE ZURICH, Ill., Jan. 27, 2011 /PRNewswire/ -- Fenwal, Inc., a global medical technology company focused on improving blood collection, separation, safety and availability, announced today the names of 16 inspiring individuals inducted into the company's 2010 Donation Hall of Fame.
Mounting effects of severe winter weather causes lowest January supply in a decade WASHINGTON, Jan.
Blood Drives Cancelled Due to Snow Drifts & Traffic Hazards Supplies of O-Negative Blood Down to Two-Day Supply NEW YORK, Dec.
These Patients Need Your Support NEW YORK, Dec.
ORLANDO, Fla., Dec. 5, 2010 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced the final results from a 5-year open-label extension study investigating the long-term efficacy and safety of NplateÂ® (romiplostim) in adult chronic immune (idiopathic) thrombocytopenic purpura (ITP).
LAKE ZURICH, Ill., Nov.
Skin cells from humans can be revamped into pro-clotting cells called platelets.
THOUSAND OAKS, Calif., Nov. 10, 2010 /PRNewswire-FirstCall/ -- Amgen Inc.
- An interdisciplinary study of social injustice.